The Technical Analyst
Select Language :
Beam Therapeutics Inc [BEAM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Beam Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Beam Therapeutics Inc is listed at the  Exchange

2.23% $33.96

America/New_York / 27 mar 2024 @ 16:00


Beam Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2 773.10 mill
EPS: -1.720
P/E: -19.74
Earnings Date: May 07, 2024
SharesOutstanding: 81.66 mill
Avg Daily Volume: 1.387 mill
RATING 2024-03-27
A
Buy
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Neutral
P/E: Strong Buy
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -19.74 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-3.36x
Company: PE -19.74 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 31.08 - 36.85

( +/- 8.50%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-13 Fmr Llc Sell 410 Common Stock
2024-02-13 Fmr Llc Sell 1 155 Common Stock
2024-02-14 Fmr Llc Sell 854 323 Common Stock
2024-02-14 Fmr Llc Sell 45 677 Common Stock
2024-01-31 Burrell Terry-ann Buy 55 000 Stock Option (Right to Buy)
INSIDER POWER
-29.02
Last 98 transactions
Buy: 1 225 467 | Sell: 2 014 865

Forecast: 16:00 - $34.00

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $34.00
Forecast 2: 16:00 - $34.00
Forecast 3: 16:00 - $34.00
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $33.96 (2.23% )
Volume 0.692 mill
Avg. Vol. 1.387 mill
% of Avg. Vol 49.89 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Beam Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Beam Therapeutics Inc

RSI

Intraday RSI14 chart for Beam Therapeutics Inc

Last 10 Buy & Sell Signals For BEAM

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:34sell$28.15N/AActive
Profile picture for
            Beam Therapeutics Inc

BEAM

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
NOD.OLMar 27 - 08:05NOK85.80
SOON.OLMar 27 - 08:05NOK67.00
ELO.OLMar 27 - 08:05NOK34.00
VEI.OLMar 27 - 08:05NOK118.00
RIVER.OLMar 27 - 08:0527.00
MAS.OLMar 27 - 08:0530.30
NAVA.OLMar 27 - 07:58NOK35.60
CARA.OLMar 27 - 08:05NOK11.52
NOL.OLMar 27 - 08:09NOK9.97
OLT.OLMar 27 - 08:05NOK222.00

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.